Reckitt Benckiser Group PLC (LSE:RKT) - Share price

Stock Report

Reckitt Benckiser Group PLC RKT

Last Price

Day Change

As of 12/08/2022
18:07:59 BST | GBX
Minimum 15 Minutes Delay.

Last Close6,542.00p
Day Range6,466.00 - 6,578.00
Mkt Cap46.57Bil
52-Wk Range4,905.16 - 6,824.00
Yield %2.68

Share Price

Total Returns 12/08/2022

 Chg (%)  
More ...
Reckitt Benckiser Group PLC2.80 
FTSE 100 TR GBP4.59
More ...
Income Statement
Operating Profit3,162.003,145.002,714.00
Net Profit-2,772.001,153.00-52.00
Reported EPS-393.00159.30-8.80
Balance Sheet
Current Assets5,033.005,314.004,862.00
Non Current Assets27,106.0025,978.0021,941.00
Total Assets32,139.0031,292.0026,946.00
Current Liabilities8,931.006,938.008,088.00
Total Liabilities22,732.0022,133.0019,493.00
Total Equity9,407.009,159.007,453.00
Cash Flow
Operating Cash Flow2,058.004,280.002,612.00
Net Change in Cash139.00149.00-350.00

Regulatory News

DateAuthor Headline
29/07/2022James Gard Top FTSE 100 Dividend Paying Stocks
UPDATED for July 2022: Earnings season is in full swing, with plenty of dividend news to catch up with
Director Dealings
More ...
09/06/2022DMr. Laxman Narasimhan6,158.4739824,511.00
15/09/2021DMr. Laxman Narasimhan5,916.9938722,899.00

Company Profile

Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.


Household & Personal Products


FTSE 100 , FTSE 350 , FTSE All Share , FTSE Eurotop 100 , FTSE Eurotop 300

Next Event 17/02/2023

Final Results
More ...
PER (E)15.65
Div Yld (E)2.63
PEG (E)5.42
Op Mrgn0.21
EPS Grwth2.63
More ...
Record Date29/04/2205/08/22
More ...
Non-Executive DirectorMr. Andrew Robert John Bonfield
Non-Executive Director, ChairmanMr. Christopher Alan Sinclair
Non-Executive DirectorMr. Olivier Bohuon
Non-Executive Director, Senior Independent DirectorMr. Nicandro Durante
Non-Executive DirectorMs. S. Sara Mathew
Non-Executive DirectorDr. Pamela Josephine Kirby
Non-Executive DirectorMs. Margherita Della Valle
Executive Director, Chief Financial OfficerMr. Jeffrey Carr
Non-Executive DirectorMrs. Mary Elaine Harris
Non-Executive DirectorMs. Elane B. Stock
Non-Executive DirectorDr. Mehmood Khan
Executive Director, Chief Executive OfficerMr. Laxman Narasimhan
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.